T Langer

Computer-aided molecular modeling, synthesis, and biological evaluation of 8-(benzyloxy)-2-phenylpyrazolo[4,3-c]quinoline as a novel benzodiazepine receptor agonist ligand.

T. Langer, P. Skolnick, R I Fryer, 1995, Journal of medicinal chemistry.

Studies on structure-activity relationships of retinoic acid receptor ligands by means of molecular modeling.

T. Langer, G. Daxenbichler, T Langer, 2000, Vitamins and hormones.

A 3D QSAR Study of Monoamino Oxidase-B Inhibitors Using the Chemical Function Based Pharmacophore Generation Approach

R. Hoffmann, S. Guccione, G. Raciti, 2001, Journal of enzyme inhibition.

Integrated in silico tools for exploiting the natural products' bioactivity.

T Langer, H Stuppner, J M Rollinger, 2006, Planta medica.

Why drugs fail--a study on side effects in new chemical entities.

C. Laggner, T. Langer, D. Schuster, 2005, Current pharmaceutical design.

Strategies for efficient lead structure discovery from natural products.

T. Langer, J. Rollinger, H. Stuppner, 2006, Current medicinal chemistry.

Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.

T. Langer, M. Hamon, M. Menziani, 1998, Journal of medicinal chemistry.

Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus.

T. Langer, J. Rollinger, H. Stuppner, 2005, Current drug discovery technologies.